Nimml Institute Inc.

Blacksburg, VA

UEI
JGBKLXXMYNT3
CAGE
8F3Y4
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
1800 Kraft Dr SW #100, Blacksburg, VA 24060, USA
Website
nimml.org
Founded
2019
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
  4. Research & Consulting Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
Mayo Clinic Arizona AI071106: "MERIT Extension Mechanisms of Allergen-induced Type 2 Immunity" R37AI071106 $375,000
Mayo Clinic Arizona The Kale Laboratory at Virginia Tech will be responsible for design, construction, expression, and purification of Alternaria beta-glucosidase genes and… R37AI071106 $123,000

Similar vendors

About the company

Nimml Institute Inc. is a 501(c)(3) non-profit research organization located in Blacksburg, Virginia, focused on precision medicine at the intersection of immunology, inflammation, and metabolism. Registered in SAM.gov since October 2019, the institute applies a transdisciplinary, team-science approach to fundamental research exploring novel immunometabolic mechanisms that influence disease severity and treatment outcomes in infectious and autoimmune diseases. As a non-profit organization, Nimml Institute Inc. primarily engages with federal agencies through grant-based research projects, with a particular emphasis on advanced scientific investigations that can potentially lead to breakthrough therapeutic approaches.

The institute has been awarded federal grants from the National Institute of Allergy and Infectious Diseases (NIAID), with a current prominent project focusing on investigating immunometabolic mechanisms related to Clostridioides difficile infection (CDI). Through sub-grant awards with Mayo Clinic Arizona, Nimml Institute Inc. has been conducting sophisticated research involving gene design, construction, expression, and protein purification, specifically working on Alternaria beta-glucosidase genes. Their research methodology includes complex scientific processes such as codon optimization for various expression systems (E. coli, Pichia, mammalian, and insect cells), enzymatic and functional assays, protein purification, endotoxin removal, and immunological pathway activation studies. The institute collaborates with academic research laboratories, such as the Kale Laboratory at Virginia Tech and Professor Kita's laboratory at Mayo Clinic, to execute detailed scientific investigations that aim to provide novel mechanistic insights for potential host-based therapeutic developments in infectious disease treatment.

Quick answers

Is Nimml Institute Inc. registered in SAM.gov?

Yes. Nimml Institute Inc.'s SAM.gov registration is active through September 15, 2027.

What is Nimml Institute Inc.'s CAGE code?

Nimml Institute Inc.'s CAGE code is 8F3Y4, and its Unique Entity ID (UEI) is JGBKLXXMYNT3.

What is Nimml Institute Inc.'s most recent federal award?

Nimml Institute Inc.'s most recent federal grant award is Immunometabolic mechanisms of protection against infection the nimml institute is a 501 (C) (3) non-profit public… (R21AI182927), from National Institute of Allergy and Infectious Diseases (NIH), on December 1, 2024.

On GovTribe

See Nimml Institute Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe